Eugene Myron Holuka

Insider Reports History

Entity
Individual
Location
11 Commerce Drive, 11 Th Floor, Cranford, NJ
Signature
/s/ Lorna A. Knick, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eugene Myron Holuka:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Citius Pharmaceuticals, Inc. Director Common Stock 2.37K $1.78K $0.75 Nov 7, 2024 Direct
CITIUS ONCOLOGY, INC. Director Stock Option (Right to Buy) 125K Dec 12, 2024 Direct
Citius Pharmaceuticals, Inc. Director Stock Option (Right to Purchase Common Stock) 125K Nov 7, 2024 Direct

Insider Reports Filed by Eugene Myron Holuka

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTOR CITIUS ONCOLOGY, INC. Dec 12, 2024 1 $0 4 Dec 16, 2024 Director
CTXR Citius Pharmaceuticals, Inc. Nov 7, 2024 1 $0 4 Nov 12, 2024 Director
CTOR CITIUS ONCOLOGY, INC. Aug 12, 2024 1 $0 4 Aug 16, 2024 Director
CTOR CITIUS ONCOLOGY, INC. Aug 12, 2024 0 $0 3 Aug 16, 2024 Director
CTXR Citius Pharmaceuticals, Inc. Mar 13, 2024 3 $0.23 4 Aug 30, 2024 Director
CTXR Citius Pharmaceuticals, Inc. Oct 10, 2023 1 $0 4 Oct 12, 2023 Director
CTXR Citius Pharmaceuticals, Inc. Oct 4, 2022 1 $0 4 Oct 6, 2022 Director
CTXR Citius Pharmaceuticals, Inc. Oct 11, 2021 1 $0 4 Oct 13, 2021 Director
CTXR Citius Pharmaceuticals, Inc. Jul 22, 2021 1 $0 4 Jul 26, 2021 Director